12:00 AM
Nov 22, 1999
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Ushercell: Phase I

Data from about 45 patients showed that Ushercell gave minimal evidence of vaginal irritation. The company plans to conduct...

Read the full 75 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >